49,590 Shares in Henry Schein, Inc. (NASDAQ:HSIC) Bought by International Assets Investment Management LLC

International Assets Investment Management LLC acquired a new position in Henry Schein, Inc. (NASDAQ:HSIC) in the fourth quarter, Holdings Channel reports. The institutional investor acquired 49,590 shares of the company’s stock, valued at approximately $3,754,000.

A number of other large investors have also recently made changes to their positions in the business. DekaBank Deutsche Girozentrale increased its stake in Henry Schein by 2.3% during the fourth quarter. DekaBank Deutsche Girozentrale now owns 987,597 shares of the company’s stock worth $74,712,000 after acquiring an additional 22,440 shares during the last quarter. Tempus Wealth Planning LLC boosted its stake in Henry Schein by 9.8% during the fourth quarter. Tempus Wealth Planning LLC now owns 3,953 shares of the company’s stock worth $299,000 after buying an additional 353 shares during the period. Arizona State Retirement System raised its stake in shares of Henry Schein by 0.4% in the fourth quarter. Arizona State Retirement System now owns 35,890 shares of the company’s stock valued at $2,717,000 after acquiring an additional 149 shares during the period. Baker Ellis Asset Management LLC purchased a new position in shares of Henry Schein during the 4th quarter worth about $4,069,000. Finally, TIAA Trust National Association grew its holdings in Henry Schein by 13.3% during the 4th quarter. TIAA Trust National Association now owns 5,188 shares of the company’s stock valued at $393,000 after purchasing an additional 608 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors.

Insider Transactions at Henry Schein

In other Henry Schein news, Vice Chairman James P. Breslawski sold 2,907 shares of the business’s stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $74.37, for a total value of $216,193.59. Following the completion of the transaction, the insider now directly owns 209,562 shares of the company’s stock, valued at $15,585,125.94. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, CEO Bradford C. Connett sold 6,430 shares of the company’s stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the transaction, the chief executive officer now owns 73,108 shares of the company’s stock, valued at approximately $5,430,462.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the firm’s stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $74.37, for a total value of $216,193.59. Following the completion of the sale, the insider now directly owns 209,562 shares in the company, valued at $15,585,125.94. The disclosure for this sale can be found here. Company insiders own 1.14% of the company’s stock.

Henry Schein Price Performance

NASDAQ HSIC opened at $73.44 on Friday. The company has a current ratio of 1.67, a quick ratio of 1.00 and a debt-to-equity ratio of 0.45. The firm has a market capitalization of $9.44 billion, a P/E ratio of 23.31, a P/E/G ratio of 1.68 and a beta of 0.87. Henry Schein, Inc. has a 12-month low of $60.01 and a 12-month high of $82.63. The firm’s fifty day simple moving average is $72.95 and its two-hundred day simple moving average is $72.35.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, May 7th. The company reported $1.10 earnings per share for the quarter, topping analysts’ consensus estimates of $1.01 by $0.09. Henry Schein had a return on equity of 14.03% and a net margin of 3.37%. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.21 billion. During the same quarter in the previous year, the firm earned $1.21 earnings per share. The company’s revenue was up 3.7% on a year-over-year basis. Analysts forecast that Henry Schein, Inc. will post 5.07 EPS for the current fiscal year.

Analyst Ratings Changes

Several brokerages have issued reports on HSIC. Evercore ISI raised their price objective on shares of Henry Schein from $79.00 to $83.00 and gave the stock an “in-line” rating in a research note on Wednesday, February 28th. Leerink Partnrs reaffirmed a “market perform” rating on shares of Henry Schein in a research report on Monday, February 26th. SVB Leerink began coverage on Henry Schein in a report on Monday, February 26th. They issued a “market perform” rating and a $78.00 price target for the company. TheStreet raised Henry Schein from a “c+” rating to a “b-” rating in a research report on Monday, February 26th. Finally, JPMorgan Chase & Co. increased their price target on Henry Schein from $82.00 to $88.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 6th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $81.73.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.